SCHEMBL2940747

SCHEMBL2940747

CC(C)N(C(=O)O)c1cc(C(C)(C)C)cc(C(C)(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 2/20 0.48
RXRB P28702 12/20 0.40
RXRA P19793 11/20 0.40
RXRG P48443 9/20 0.40
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
ALDH1A1 P00352 2/20 0.35
TP53 P04637 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 1/20 0.35
ACHE P22303 1/20 0.34
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.33
BLM P54132 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MLYCD O95822 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL77791 0.83 ACHE (0.47) HDAC8RXRBRXRAALDH1A1TP53
SCHEMBL5260445 0.75 HTR2C (0.41) HDAC8ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL11103938 0.75 RXRB (0.45) RXRBRXRARXRGGABRA1GABRB2
SCHEMBL24237327 0.71 GABRA1 (0.42) HDAC8RXRBRXRARXRGGABRA1
SCHEMBL2543696 0.70 ALDH1A1 (0.63) ALDH1A1TP53SMN1; SMN2LMNAMLYCD
SCHEMBL16776735 0.69 RXRB (0.38) RXRBRXRARXRGGABRA1GABRB2
SCHEMBL7931675 0.68 GABRA1 (0.44) HDAC8RXRBRXRARXRGGABRA1
SCHEMBL11473066 0.68 RXRA (0.62) HDAC8RXRBRXRARXRGGABRA1
SCHEMBL22235910 0.67 ALDH1A1 (0.45) HDAC8RXRBRXRARXRGALDH1A1
SCHEMBL11211561 0.67 AKR1C3 (0.50) RXRBRXRARXRGGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010149688-A2 ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2010-12-29 WO disclosed